 |
PharmacodynamicsPhosphorylated proteins, angiogenesis, apoptosis, DNA repair, pathway-resistance markers, tissues, CTCs, CECs, surrogate specimens |
 |
Molecular AnalysisSingle cell nucleic acid-based analysis, genetic mutations, amplification, and translocations, FISH, gene expression |
 |
Clinical Assay DevelopmentMultiplex assays, validated biomarkers, translational research studies, proof of concept, biomarker screening, integrated platform technologies |
 |
Multiplex Flow CytometryMulti-fluororchrome panels, rare cell detection, pharmacodynamic analysis, enumeration and phenotyping following enrichment |
 |
Circulating Tumor Cells
|
 |
ApoStreamTM TechnologyAntibody-independent, viable CTCs from various cancers, high recovery, and low starting volume |
 |
Validated BiomarkersApoptosis, AKT, EGF, VEGF, P53, DNA repair |
